Suppression of GRIM19 expression impaired ubiquitination-mediated degradation of Bcl-xL in bladder cancer cells, conferring to promotion of cisplatin chemoresistance (85). The gene discussed is BCL2L1; the disease is urinary bladder carcinoma.